The DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
Open accessAbstract
Chemokines are a family of small, secreted cytokines which regulate a variety of cell functions. The C-X-C motif chemokine ligand 12 (CXCL12) binds to C-X-C chemokine receptor type 4 (CXCR4) and C-X-C chemokine receptor type 7 (CXCR7). The interaction of CXCL12 and its receptors subsequently induces downstream signaling pathways with broad effects on chemotaxis, cell proliferation, migration, and gene expression. Accumulating evidence suggests that the CXCL12/CXCR4/CXCR7 axis plays a pivotal role in tumor development, survival, angiogenesis, metastasis, and tumor microenvironment. In addition, this chemokine axis promotes chemoresistance in cancer therapy via complex crosstalk with other pathways. Multiple small molecules targeting CXCR4/CXCR7 have been developed and used for preclinical and clinical cancer treatment. In this review, we describe the roles of the CXCL12/CXCR4/CXCR7 axis in cancer progression and summarize strategies to develop novel targeted cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
The Role of CXCR7/RDC1 as a Chemokine Receptor for CXCL12/SDF-1 in Prostate Cancer
Wang, J., Shiozawa, Y., Wang, J., Wang, Y., Jung, Y., Pienta, K. J., Mehra, R., Loberg, R., & Taichman, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707465200 · Cited by 457
RetractedA Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer
Wang, J., Wang, J., Dai, J., Jung, Y., Wei, C.-L., Wang, Y., Havens, A. M., Hogg, P. J., Keller, E. T., Pienta, K. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2971 · Cited by 152
RetractedEffect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo
Meijer, J. M., Ogink, J., & Roos, E. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604727 · Cited by 59
RetractedLiao, A., Shi, R., Jiang, Y., Tian, S., Li, P., Song, F., Qu, Y., Li, J., Yun, H., & Yang, X. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9006-0 · Cited by 40
RetractedNew functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Feig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100
Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity
Griffith, J. W., Sokol, C. L., & Luster, A. D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120145 · Cited by 2,059
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
VEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,768
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
Tachibana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S.-I., et al. (1998) · Nature · doi:10.1038/31261 · Cited by 1,525
TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia
Bhowmick, N. A., Chytil, A., Plieth, D., Gorska, A. E., Dumont, N., Shappell, S., Washington, M. K., Neilson, E. G., & Moses, H. L. (2004) · Science · doi:10.1126/science.1090922 · Cited by 1,401
Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,269
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,263
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2006) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,170
The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes
Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y. C., Harriague, J., Moepps, B., Arenzana-Seisdedos, F., Thelen, M., & Bachelerie, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508234200 · Cited by 1,040
Kioi, M., Vogel, H., Schultz, G., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 773
Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska‐Wieczorek, A., Ratajczak, J., & Ratajczak, M. Z. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0342 · Cited by 759
Selective Amplification And Cloning Of Four New Members Of The G Protein-coupled Receptor Family
Libert, F., Parmentier, M., Lefort, A., Dinsart, C., Van Sande, J., Maenhaut, C., Simons, M.-J., Dumont, J. E., & Vassart, G. (1989) · Science · doi:10.1126/science.2541503 · Cited by 641
Sierro, F., Biben, C., Martínez-Muñoz, L., Mellado, M., Ransohoff, R. M., Li, M., Woehl, B., Leung, H., Groom, J., Batten, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702229104 · Cited by 624
Busillo, J. M., & Benovic, J. L. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.11.002 · Cited by 617
CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling
Levoye, A., Balabanian, K., Baleux, F., Bachelerie, F., & Lagane, B. (2009) · Blood · doi:10.1182/blood-2008-12-196618 · Cited by 613
Ganju, R. K., Brubaker, S. A., Meyer, J., Dutt, P., Yang, Y., Qin, S., Newman, W., & Groopman, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23169 · Cited by 613
Rollins, B. J. (1997) · PubMed · Cited by 603
Luther, S. A., Bidgol, A., Hargreaves, D. C., Schmidt, A., Xu, Y., Paniyadi, J., Matloubian, M., & Cyster, J. G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.424 · Cited by 584
Impact of the physical microenvironment on tumor progression and metastasis
Spill, F., Reynolds, D. S., Kamm, R. D., & Zaman, M. H. (2016) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2016.02.007 · Cited by 581
Barcellos‐Hoff, M. H., & Ravani, S. A. (2000) · PubMed · Cited by 536
Miao, Z., Luker, K. E., Summers, B. C., Berahovich, R., Bhojani, M. S., Rehemtulla, A., Kleer, C. G., Essner, J. J., Nasevicius, A., Luker, G. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610444104 · Cited by 533
Zeng, Z., Xi Shi, Y., Samudio, I. J., Wang, R.-Y., Ling, X., Frolova, O., Levis, M., Rubin, J. B., Negrin, R. R., Estey, E. H., et al. (2009) · Blood · doi:10.1182/blood-2008-05-158311 · Cited by 518
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 471
CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
Naumann, U., Cameroni, E., Pruenster, M., Mahabaleshwar, H., Raz, E., Zerwes, H.-G., Rot, A., & Thelen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009175 · Cited by 470
CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers
Burger, J. A., & Peled, A. (2009) · Leukemia · doi:10.1038/leu.2008.299 · Cited by 462
Flomenberg, N. (2005) · Blood · doi:10.1182/blood-2005-02-0468 · Cited by 460
Chen, Y., Ramjiawan, R. R., Reiberger, T., Ng, M. R., Hato, T., Huang, Y., Ochiai, H., Kitahara, S., Unan, E. C., Reddy, T. P., et al. (2015) · Hepatology · doi:10.1002/hep.27665 · Cited by 451
G Protein regulation of MAPK networks
Goldsmith, Z. G., & Dhanasekaran, D. N. (2007) · Oncogene · doi:10.1038/sj.onc.1210407 · Cited by 447
Shaked, Y., Henke, E., Roodhart, J. M. L., Mancuso, P., Langenberg, M. H. G., Colleoni, M., Daenen, L. G., Man, S., Xu, P., Emmenegger, U., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.001 · Cited by 440
Chemokine receptor homo- or heterodimerization activates distinct signaling pathways
Mellado, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2497 · Cited by 432
The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
Zeelenberg, I. S., Stalle, L. R.-V., & Roos, E. (2003) · PubMed · Cited by 430
The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis
Ratajczak, M. Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., & Ratajczak, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404357 · Cited by 424
Chemokines and Their Receptors in the Central Nervous System
Bajetto, A., Bonavia, R., Barbero, S., Florio, T., & Schettini, G. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0214 · Cited by 416
CXC chemokines: the regulatory link between inflammation and angiogenesis
Romagnani, P., Lasagni, L., Annunziato, F., Serio, M., & Romagnani, S. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.02.006 · Cited by 409
Chemokine Receptors in Human Endothelial Cells
Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E., & Stadel, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4282 · Cited by 407
Leukemia Stem Cells and Microenvironment: Biology and Therapeutic Targeting
Konopleva, M. Y., & Jordan, C. T. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.0904 · Cited by 402
Uy, G. L., Rettig, M. P., Motabi, I. H., McFarland, K., Trinkaus, K. M., Hladnik, L. M., Kulkarni, S., Abboud, C. N., Cashen, A. F., Stockerl-Goldstein, K. E., et al. (2012) · Blood · doi:10.1182/blood-2011-10-383406 · Cited by 400
Zagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., Yee, H., Voura, E. B., & Newcomb, E. W. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700482 · Cited by 396
CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
Duda, D. G., Kozin, S. V., Kirkpatrick, N. D., Xu, L., Fukumura, D., & Jain, R. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2636 · Cited by 395
The chemokine SDF1 regulates migration of dentate granule cells
Bagri, A., Gurney, T., He, X., Zou, Y.-R., Littman, D. R., Tessier-Lavigne, M., & Pleasure, S. J. (2002) · Development · doi:10.1242/dev.129.18.4249 · Cited by 386
Regulation of Bad Phosphorylation and Association with Bcl-xL by the MAPK/Erk Kinase
Scheid, M. P., Schubert, K. M., & Duronio, V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31108 · Cited by 384
Sun, Y., Cheng, Z., Ma, L., & Pei, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207294200 · Cited by 382
Therapeutic Inflammatory Monocyte Modulation Using Immune-Modifying Microparticles
Getts, D. R., Terry, R. L., Getts, M. T., Deffrasnes, C., Müller, M., van Vreden, C., Ashhurst, T. M., Chami, B., McCarthy, D., Wu, H., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007563 · Cited by 378
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
Vicari, A. P., & Caux, C. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00033-8 · Cited by 351
Marchesi, F., Monti, P., Leone, B. E., Zerbi, A., Vecchi, A., Piemonti, L., Mantovani, A., & Allavena, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1343 · Cited by 339
Barbero, S., Bonavia, R., Bajetto, A., Porcile, C., Pirani, P., Ravetti, J. L., Zona, G., Spaziante, R., Florio, T., & Schettini, G. (2003) · PubMed · Cited by 336
CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
Liang, Z., Brooks, J., Willard, M., Liang, K., Yoon, Y., Kang, S., & Shim, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.182 · Cited by 334
The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
Sánchez-Martín, L., Estecha, A., Samaniego, R., Sánchez-Ramón, S., Vega, M. Á., & Sánchez-Mateos, P. (2011) · Blood · doi:10.1182/blood-2009-12-258186 · Cited by 325
Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer
Curiel, T. J., Cheng, P., Mottram, P., Alvarez, X., Moons, L., Evdemon-Hogan, M., Wei, S., Zou, L., Kryczek, I., Hoyle, G., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1272 · Cited by 297
Hattermann, K., Held-Feindt, J., Lucius, R., Müerköster, S. S., Penfold, M. E. T., Schall, T. J., & Mentlein, R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3642 · Cited by 295
Zabel, B. A., Wang, Y., Lewén, S., Berahovich, R. D., Penfold, M. E. T., Zhang, P., Powers, J., Summers, B. C., Miao, Z., Zhao, B., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900269 · Cited by 294
Ao, M., Franco, O. E., Park, D., Raman, D., Williams, K., & Hayward, S. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3946 · Cited by 278
Protein profiles associated with survival in lung adenocarcinoma
Chen, G., Gharib, T. G., Wang, H., Huang, C.-C., Kuick, R., Thomas, D. G., Shedden, K. A., Misek, D. E., Taylor, J. M. G., Giordano, T. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2233850100 · Cited by 277
Kijima, T., Maulik, G., Ma, P. C., Tibaldi, E. V., Turner, R. E., Rollins, B. J., Sattler, M., Johnson, B. E., & Salgia, R. (2002) · PubMed · Cited by 273
Wang, J.-F., Park, I.-W., & Groopman, J. E. (2000) · Blood · doi:10.1182/blood.v95.8.2505 · Cited by 254
Kim, S. Y., Lee, C. H., Midura, B. V., Yeung, C., Mendoza, A., Hong, S. H., Ren, L., Wong, D., Korz, W., Merzouk, A., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9133-3 · Cited by 253
Righi, E., Kashiwagi, S., Yuan, J., Santosuosso, M., Leblanc, P., Ingraham, R., Forbes, B., Edelblute, B., Collette, B., Xing, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3143 · Cited by 245
Kukreja, P., Abdel-Mageed, A. B., Mondal, D., Liu, K., & Agrawal, K. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1293 · Cited by 209
New nomenclature for atypical chemokine receptors
Bachelerie, F., Graham, G. J., Locati, M., Mantovani, A., Murphy, P. M., Nibbs, R., Rot, A., Sozzani, S., & Thelen, M. (2014) · Nature Immunology · doi:10.1038/ni.2812 · Cited by 200
Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies
Kufareva, I., Salanga, C. L., & Handel, T. M. (2015) · Immunology & Cell Biology · doi:10.1038/icb.2015.15 · Cited by 200
Bosco, M. C., Puppo, M., Santangelo, C., Anfosso, L., Pfeffer, U., Fardin, P., Battaglia, F., & Varesio, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1941 · Cited by 199
Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis
Teng, F., Tian, W.-Y., Wang, Y.-M., Zhang, Y.-F., Guo, F., Zhao, J., Gao, C., & Xue, F.-X. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0231-4 · Cited by 198
Chemokines in tumor progression and metastasis
Tanaka, T., Bai, Z., Srinoulprasert, Y., Yang, B., Hayasaka, H., & Miyasaka, M. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00059.x · Cited by 192
The G protein Gα12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain
Jiang, Y., Ma, W., Wan, Y., Kozasa, T., Hattori, S., & Huang, X.-Y. (1998) · Nature · doi:10.1038/27454 · Cited by 186
Pathological roles of the homeostatic chemokine CXCL12
Janssens, R., Struyf, S., & Proost, P. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.10.004 · Cited by 185
Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis
Pan, J., Mestas, J., Burdick, M. D., Phillips, R. J., Thomas, G. V., Reckamp, K., Belperio, J. A., & Strieter, R. M. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-56 · Cited by 184
Gerits, N., Kostenko, S., Shiryaev, A., Johannessen, M., & Moens, U. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.02.022 · Cited by 182
Li, X., Ma, Q., Xu, Q., Liu, H., Lei, J., Duan, W., Bhat, K., Wang, F., Wu, E., & Wang, Z. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.035 · Cited by 181
Singh, R. K., & Lokeshwar, B. L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2769 · Cited by 179
CXCR4 Chemokine Receptor Mediates Prostate Tumor Cell Adhesion through α5 and β3 Integrins
Engl, T., Relja, B., Marian, D., Blumenberg, C., Müller, I., Beecken, W.-D., Jones, J., Ringel, E. M., Bereiter-Hahn, J., Jonas, D., et al. (2006) · Neoplasia · doi:10.1593/neo.05694 · Cited by 179
Vascular Gene Expression in Nonneoplastic and Malignant Brain
Madden, S. L., Cook, B. P., Nacht, M., Weber, W. D., Callahan, M. R., Jiang, Y., Dufault, M. R., Zhang, X., Zhang, W., Walter-Yohrling, J., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63324-x · Cited by 179
Kang, H., Watkins, G., Parr, C., Douglas-Jones, A., Mansel, R. E., & Jiang, W. G. (2005) · Breast Cancer Research · doi:10.1186/bcr1022 · Cited by 178
Suzuki, Y., Rahman, M., & Mitsuya, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3064 · Cited by 176
Kim, J., Mori, T., Chen, S. L., Amersi, F. F., Martinez, S. R., Kuo, C., Turner, R. R., Ye, X., Bilchik, A. J., Morton, D. L., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000217690.65909.9c · Cited by 175
Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration
De Clercq, E. (2019) · Antiviral Chemistry and Chemotherapy · doi:10.1177/2040206619829382 · Cited by 174
Jiang, Y.-P., Wu, X.-H., Shi, B., Wu, W.-X., & Yin, G.-R. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.02.036 · Cited by 173
Würth, R., Bajetto, A., Harrison, J. K., Barbieri, F., & Florio, T. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00144 · Cited by 172
Beider, K., Bitner, H., Leiba, M., Gutwein, O., Koren-Michowitz, M., Ostrovsky, O., Abraham, M., Wald, H., Galun, E., Peled, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2207 · Cited by 171
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
Sleightholm, R. L., Neilsen, B. K., Li, J., Steele, M. M., Singh, R. K., Hollingsworth, M. A., & Oupicky, D. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.05.012 · Cited by 171
Qiao, Y., Zhang, C., Li, A., Wang, D., Luo, Z., Ping, Y., Zhou, B., Liu, S., Li, H., Yue, D., et al. (2018) · Oncogene · doi:10.1038/onc.2017.387 · Cited by 166
Nomiyama, H., Osada, N., & Yoshie, O. (2012) · Genes to Cells · doi:10.1111/gtc.12013 · Cited by 164
Sehgal, A., Keener, C. L., Boynton, A. L., Warrick, J., & Murphy, G. P. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199810)69:2<99::aid-jso10>3.0.co;2-m · Cited by 158
Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis
Hernández, L. B., Magalhães, M. A. O., Coniglio, S. J., Condeelis, J. S., & Segall, J. E. (2011) · Breast Cancer Research · doi:10.1186/bcr3074 · Cited by 153
Hu, T., Yao, Y., Yu, S., Han, L., Wang, W., Guo, H., Tian, T., Ruan, Z.-P., Kang, X., Wang, J., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.012 · Cited by 149
SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy
Roccaro, A. M., Sacco, A., Purschke, W. G., Moschetta, M., Buchner, K., Maasch, C., Zboralski, D., Zöllner, S. K., Vonhoff, S., Mishima, Y., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.042 · Cited by 148
Cloning and expression of the human vasoactive intestinal peptide receptor.
Sreedharan, S. P., Robichon, A., Peterson, K. E., & Goetzl, E. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4986 · Cited by 145
Li, H., Yang, L., Fu, H., Yan, J., Wang, Y., Guo, H., Hao, X., Xu, X., Jin, T., & Zhang, N. (2013) · Nature Communications · doi:10.1038/ncomms2680 · Cited by 140
Ödemis, V., Lipfert, J., Kraft, R., Hajek, P., Abraham, G., Hattermann, K., Mentlein, R., & Engele, J. (2011) · Glia · doi:10.1002/glia.22271 · Cited by 139
Jee, S., Chu, C., Chiu, H.-C., Huang, Y., Tsai, W.-L., Liao, Y., & Kuo, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23497.x · Cited by 139
Hwang, T., Liang, Y. J., Chien, K., & Yu, J. (2006) · PROTEOMICS · doi:10.1002/pmic.200500345 · Cited by 133
Hassan, S. N., Buchanan, M., Jahan, K., Aguilar‐Mahecha, A., Gaboury, L. A., Muller, W. J., Al-Sawafi, Y., Mourskaia, A., Siegel, P. M., Salvucci, O., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25665 · Cited by 126
Gao, Z., Wang, X., Wu, K., Zhao, Y., & Hu, G. (2010) · Pancreatology · doi:10.1159/000236012 · Cited by 123
Singh, A. P., Arora, S., Bhardwaj, A., Srivastava, S. K., Kadakia, M., Wang, B., Grizzle, W. E., Owen, L. B., & Singh, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.409581 · Cited by 122
Yu, T., Wu, Y., Helman, J. I., Wen, Y.-M., Wang, C., & Li, L. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0386 · Cited by 121
Dubrovska, A., Hartung, A., Bouchez, L. C., Walker, J. R., Reddy, V. A., Cho, C. Y., & Schultz, P. G. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.105 · Cited by 119
Falco, V. D., Guarino, V., Avilla, E., Castellone, M. D., Salerno, P., Salvatore, G., Faviana, P., Basolo, F., Santoro, M. M., & Melillo, R. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0899 · Cited by 119
Metalloproteinases and their inhibitors in angiogenesis
Lafleur, M. A., Handsley, M. M., & Edwards, D. R. (2003) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399403006628 · Cited by 117
Decoy Receptor CXCR7 Modulates Adrenomedullin-Mediated Cardiac and Lymphatic Vascular Development
Klein, K. R., Karpinich, N. O., Espenschied, S. T., Willcockson, H. H., Dunworth, W. P., Hoopes, S. L., Kushner, E. J., Bautch, V. L., & Caron, K. M. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.07.012 · Cited by 116
CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer
Wu, Y.-C., Tang, S., Sun, G.-H., & SUN, K.-H. (2015) · Oncogene · doi:10.1038/onc.2015.274 · Cited by 112
Macrophages may promote cancer growth via a GM-CSF/HB-EGF paracrine loop that is enhanced by CXCL12
Rigo, A., Gottardi, M., Zamò, A., Mauri, P., Bonifacio, M., Krampera, M., Damiani, E., Pizzolo, G., & Vinante, F. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-273 · Cited by 112
Katoh, H., Hosono, K., Ito, Y., Suzuki, T., Ogawa, Y., Kubo, H., Kamata, H., Mishima, T., Tamaki, H., Sakagami, H., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090607 · Cited by 111
Wang, Z., Ma, Q., Liu, Q., Yu, H., Zhao, L., Shen, S., & Yao, J. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604745 · Cited by 111
Imaging chemokine receptor dimerization with firefly luciferase complementation
Luker, K. E., Gupta, M., & Luker, G. D. (2008) · The FASEB Journal · doi:10.1096/fj.08-116749 · Cited by 109
Wani, N. A., Nasser, M. W., Ahirwar, D. K., Zhao, H., Miao, Z., Shilo, K., & Ganju, R. K. (2014) · Breast Cancer Research · doi:10.1186/bcr3665 · Cited by 108
Saini, V., Staren, D. M., Ziarek, J. J., Nashaat, Z. N., Campbell, E. M., Volkman, B. F., Marchese, A., & Majetschak, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.233742 · Cited by 97
CXCR7 Targeting and Its Major Disease Relevance
Wang, C., Chen, W., & Shen, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00641 · Cited by 96
Self-citationCXCL12 G801A Polymorphism Is a Risk Factor for Sporadic Prostate Cancer Susceptibility
Hirata, H., Hinoda, Y., Kikuno, N., Kawamoto, K., Dahiya, A. V., Suehiro, Y., Tanaka, Y., & Dahiya, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0859 · Cited by 94
CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth
Beider, K., Begin, M., Abraham, M., Wald, H., Weiss, I. D., Wald, O., Pikarsky, E., Zeira, E., Eizenberg, O., Galun, E., et al. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.11.010 · Cited by 91
Hayashi, H., & Kume, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.183 · Cited by 88
Monnier, J., Boissan, M., L’Helgoualc’h, A., Lacombe, M., Turlin, B., Zucman‐Rossi, J., Théret, N., Piquet‐Pellorce, C., & Samson, M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.044 · Cited by 87
Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis
Martínez-Ordóñez, A., Seoane, S., Cabezas‐Sainz, P., Eiró, N., Sendón-Lago, J., Macia, M., García‐Caballero, T., González, L. O., Sanchez, L. E., Vizoso, F. J., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0036-8 · Cited by 87
CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells
Ieranò, C., Santagata, S., Napolitano, M., Guardia, F., Grimaldi, A., Antignani, E., Botti, G., Consales, C., Riccio, A., Nanayakkara, M., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.269 · Cited by 86
Barbieri, F., Bajetto, A., & Florio, T. (2009) · Journal of Oncology · doi:10.1155/2010/426956 · Cited by 85
The Peptidomimetic CXCR4 Antagonist TC14012 Recruits β-Arrestin to CXCR7
Gravel, S., Malouf, C., Boulais, P. E., Berchiche, Y. A., Oishi, S., Fujii, N., Leduc, R., Sinnett, D., & Heveker, N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.147470 · Cited by 85
Zhang, S., Qi, L., Li, M., Zhang, D., Xu, S., Wang, N., & Sun, B. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-62 · Cited by 84
The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia
Thomas, R. M., Kim, J., Revelo-Penafiel, M. P., Angel, R., Dawson, D. W., & Lowy, A. M. (2008) · Gut · doi:10.1136/gut.2007.143941 · Cited by 83
Role of chemokine receptor CXCR7 in bladder cancer progression
Hao, M., Zheng, J., 侯恺林, Wang, J., Chen, X., Lu, X., 卜, 军., Xu, C., Shen, K., & Wang, J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.04.007 · Cited by 82
Bartolomé, R. A., Ferreiro, S., Miquilena-Colina, M. E., Martínez‐Prats, L., Soto‐Montenegro, M. L., García‐Bernal, D., Vaquero, J. J., Agami, R., Delgado, R. B., Desco, M., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080636 · Cited by 82
Ma, W., Liu, Y., Ellison, N., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445510 · Cited by 81
Chemokine signaling in cancer: One hump or two?
Rubin, J. B. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.10.001 · Cited by 80
Katoh (2009) · International Journal of Oncology · doi:10.3892/ijo_00000514 · Cited by 76
An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
Kwong, J., Kulbe, H., Wong, D., Chakravarty, P., & Balkwill, F. R. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0966 · Cited by 75
CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro
Krohn, A., Song, Y., Muehlberg, F. L., Droll, L. H., Beckmann, C., & Alt, E. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.005 · Cited by 75
Princen, K., Hatse, S., Vermeire, K., Clercq, E. D., & Schols, D. (2002) · Cytometry Part A · doi:10.1002/cyto.a.10008 · Cited by 74
The role of chemokine receptor CXCR4 in lung cancer
Gangadhar, T. C., Nandi, S., & Salgia, R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.6.11233 · Cited by 73
Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis.
Ghanem, I., Riveiro, M. E., Paradis, V., Faivre, S. J., de Parga, P. V., & Raymond, É. (2014) · PubMed Central · Cited by 70
Secretion of phosphoglycerate kinase from tumour cells is controlled by oxygen-sensing hydroxylases
Daly, E. B., Wind, T., Jiang, X., Sun, L. L., & Hogg, P. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.11.004 · Cited by 70
Chaudary, N., Pintilie, M., Jelveh, S., Lindsay, P. E., Hill, R. P., & Milosevic, M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1730 · Cited by 70
T lymphocytes on the move: chemokines, PI 3-kinase and beyond
Ward, S. G. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.12.004 · Cited by 69
Qian, D., Lu, Z., Xu, Q., Wu, P., Tian, L., Zhao, L., Cai, B., Yin, J., Wu, Y. F., Staveley-O’Carroll, K. F., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.024 · Cited by 68
Ghobrial, I. M., Liu, C., Zavidij, O., Azab, A. K., Baz, R., Laubach, J. P., Mishima, Y., Armand, P. A., Munshi, N. C., Basile, F. G., et al. (2019) · American Journal of Hematology · doi:10.1002/ajh.25627 · Cited by 67
Parmo‐Cabañas, M., Molina‐Ortiz, I., Matías-Román, S., García‐Bernal, D., Carvajal‐Vergara, X., Valle, I., Pandiella, A., Arroyo, A. G., & Teixidó, J. (2005) · The Journal of Pathology · doi:10.1002/path.1876 · Cited by 66
The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma
Li, X., Li, P., Chang, Y., Xu, Q., Wu, Z., Ma, Q., & Wang, Z. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2020-8 · Cited by 66
Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
Liberman, J., Sartelet, H., Flahaut, M., Mühlethaler‐Mottet, A., Coulon, A., Nyalendo, C., Vassal, G., Joseph, J., & Groß, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043665 · Cited by 66
Endothelial CXCR7 regulates breast cancer metastasis
Stacer, A. C., Fenner, J., Cavnar, S. P., Xiao, A., Zhao, S. G., Chang, S. L., Salomonnson, A., Luker, G. D., & Luker, G. D. (2015) · Oncogene · doi:10.1038/onc.2015.236 · Cited by 64
Ueda, Y., Neel, N., Schutyser, E., Raman, D., & Richmond, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3579 · Cited by 63
Salazar, N., Carlson, J. C., Huang, K., Zheng, Y., Oderup, C., Gross, J. L., Jang, A., Burke, T. M., Lewén, S., Scholz, A., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.030 · Cited by 62
Peng, Y., Wang, G., Huo, H., Li, Q., Zhao, Y., & Liu, Y. (2014) · Medical Oncology · doi:10.1007/s12032-014-0377-x · Cited by 57
CXCR7 receptors facilitate the progression of colon carcinoma within lung not within liver
Guillemot, É., Karimdjee-Soilihi, B., Pradelli, E., Benchetrit, M., Goguet, E., Ma, M., Larbret, F., Michiels, J., Birnbaum, D., Alemanno, P., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.503 · Cited by 56
Ali, A. A., Kim, S. H., Kim, M. J., Choi, M. Y., Kang, S. S., Cho, G. J., Kim, Y. S., Choi, J., & Choi, W. S. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.2309 · Cited by 56
Guo, Z., Yang, L., Qian, F., Wang, Y., Yu, X., Ji, C., Cui, W., Xiang, D., Zhang, X., Zhang, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8236 · Cited by 54
Saigusa, S., Toiyama, Y., Tanaka, K., Yokoe, T., Okugawa, Y., Kawamoto, A., Yasuda, H., Inoue, Y., Miki, C., & Kusunoki, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0970-y · Cited by 53
Beloribi‐Djefaflia, S., Siret, C., & Lombardo, D. (2014) · Oncoscience · doi:10.18632/oncoscience.96 · Cited by 52
Heckmann, D., Maier, P., Laufs, S., Li, L., Sleeman, J. P., Trunk, M. J., Leupold, J. H., Wenz, F. K., Zeller, W. J., Früehauf, S., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0582 · Cited by 49
CXCR4/CCR5 Down-modulation and Chemotaxis Are Regulated by the Proteasome Pathway
Fernandis, A. Z., Cherla, R. P., Chernock, R. D., & Ganju, R. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200750200 · Cited by 48
Stromal Cell-Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer
Weekes, C. D., Song, D., Arcaroli, J. J., Wilson, L. A., Rubio‐Viqueira, B., Cusatis, G., Garrett-Mayer, E. S., Messersmith, W. A., Winn, R. A., & Hidalgo, M. M. (2012) · Neoplasia · doi:10.1593/neo.111810 · Cited by 48
Zhi, Y., Lu, H., Duan, Y., Sun, W.-S. W., Guan, G., Dong, Q., & Yang, C.-M. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.2032 · Cited by 47
Luca, A. D., D’Alessio, A., Gallo, M., Maiello, M. R., Bode, A. M., & Normanno, N. (2013) · Cell Cycle · doi:10.4161/cc.26899 · Cited by 47
Chu, C., Cha, S.-T., Lin, W.-C., Lu, P., Tan, C., Chang, C.-C., Lin, B.-R., Jee, S., & Kuo, M. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn228 · Cited by 47
Chang, C.-C., Chen, S.-C., Hsieh, Y., Chen, Y., Chen, T., Chu, Y.-H., Ma, H.-J., Chou, M., Tsai, H., & Yang, S. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2009.092 · Cited by 45
Yu, P., Zhang, Z., Li, S., Wen, X., Quan, W., Tian, Q., Chen, J., Zhang, J., & Jiang, R. (2016) · Cell Proliferation · doi:10.1111/cpr.12231 · Cited by 41
Li, B., Zeng, Y. C., Reeves, P. M., Ran, C., Liu, Q., Qu, X., Liang, Y., Liu, Z., Yuan, J., Leblanc, P. R., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0530 · Cited by 40
Sakai, N., Yoshidome, H., Shida, T., Kimura, F., Shimizu, H., Ohtsuka, M., Takeuchi, D., Sakakibara, M., & Miyazaki, M. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9433-5 · Cited by 39
QIN, G., Chen, Y., Li, H., Xu, S., Li, Y., Sun, J. P., Rao, W., CHEN, C., Du, M., HE, K., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5215 · Cited by 38
SDF-1α upregulation of MMP-2 is mediated by p38 MAPK signaling in pancreatic cancer cell lines
Pan, F., Ma, S., Cao, W.-K., Liu, H., Chen, F., Chen, X., & Shi, R. (2013) · Molecular Biology Reports · doi:10.1007/s11033-012-2225-4 · Cited by 35
Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia
Crowther-Swanepoel, D., Qureshi, M., Dyer, M. J. S., Matutes, E., Dearden, C. E., Catovsky, D., & Houlston, R. S. (2009) · Blood · doi:10.1182/blood-2009-07-235184 · Cited by 34
Avraham, S., Korin, B., Aviram, S., Shechter, D., Shaked, Y., & Aronheim, A. (2019) · Oncogene · doi:10.1038/s41388-019-0692-y · Cited by 33
Lv, S., Yang, Y., Kwon, S., Han, M., FangFang, Z., Kang, H., Dai, C., & Wang, R. (2013) · Histopathology · doi:10.1111/his.12321 · Cited by 32
Geng, F., Guo, J., Guo, Q., Xie, Y., Dong, L., Zhou, Y., Liu, C., Yu, B., Wu, H., Wu, J., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.06.012 · Cited by 32
Hu, Y., Zang, J., Qin, X., et al. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s124757 · Cited by 30
Komorowski, M. P., McGray, A. R., Kołakowska, A., Eng, K. H., Gil, M., Opyrchal, M., Litwińska, B., Nemeth, M. J., Odunsi, K. O., & Kozbor, D. (2016) · Molecular Therapy — Oncolytics · doi:10.1038/mto.2016.34 · Cited by 29
Mao, W., Yi, X., Qin, J., Tian, M., & Jin, G. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1831-2 · Cited by 27
Liu, X., Zhou, Y., Peng, J., Xie, B., Shou, Q., & Wang, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00495 · Cited by 26
Bai, Y., Yang, Y., Yan, Y., Zhong, J., Blee, A. M., Pan, Y., Ma, T., Karnes, R. J., Jiménez, R. E., Xu, W., et al. (2019) · Theranostics · doi:10.7150/thno.33292 · Cited by 23
Guembarovski, A. L., Guembarovski, R. L., Hirata, B. K. B., Vitiello, G. A. F., Suzuki, K. M., Enokida, M. T., Watanabe, M. A. E., & Reiche, E. M. V. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4215-7 · Cited by 22
Matsusaka, S., Cao, S., Hanna, D. L., Sunakawa, Y., Ueno, M., Mizunuma, N., Zhang, W., Yang, D., Ning, Y., Stintzing, S., et al. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.59 · Cited by 16
Liu, Z., Teng, X., Meng, X., & Wang, B. (2014) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-12-348 · Cited by 12
ShRNA-mediated knock-down of CXCR7 increases TRAIL-sensitivity in MCF-7 breast cancer cells
Gao, W., Mei, X., Wang, J., Zhang, X., & Yuan, Y. (2015) · Tumor Biology · doi:10.1007/s13277-015-3432-0 · Cited by 11
CXCR7 maintains osteosarcoma invasion after CXCR4 suppression in bone marrow microenvironment
Han, Y. Y., Wu, C., Wang, J., & Liu, N. (2017) · Tumor Biology · doi:10.1177/1010428317701631 · Cited by 11
Cited by
Inflammation and aging: signaling pathways and intervention therapies
Li, X., Li, C., Zhang, W., Wang, Y., Qian, P., & Huang, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01502-8 · Cited by 1,443
“chemokine receptor (CXCR) 4 serves as a crucial mediator in numerous physiological and pathological processes, including inflammatory responses of the immune systems, regulation of hematopoiesis, induction of angiogenesis, as well as tumor invasion and metastasis.(37) Mice with disrupted CXCR4 receptors experience a r…”
BackgroundCambier, S., Gouwy, M., & Proost, P. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-00974-6 · Cited by 591
Towards targeting of shared mechanisms of cancer metastasis and therapy resistance
Weiss, F., Lauffenburger, D., & Friedl, P. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-021-00427-0 · Cited by 293
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Rodríguez, F., Caruana, P., De la Fuente, N., Español, P., Gámez, M., Balart, J., Llurba, E., Rovira, R., Ruiz, R., Martín-Lorente, C., et al. (2022) · Biomolecules · doi:10.3390/biom12060784 · Cited by 274
Radiotheranostics in oncology: Making precision medicine possible
Aboagye, E. O., Barwick, T. D., & Haberkorn, U. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21768 · Cited by 131
Metadata
- Authors
- Shi, Y., Riese, D. J., & Shen, J.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-12-08
- Volume
- 11
- Pages
- 574667-574667
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3111751350
- Cited by
- 336
- References
- 184
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.